Zobrazeno 1 - 10
of 54
pro vyhledávání: '"KAZUHIKO KIDO"'
Autor:
Kazuhiko Kido, Yasir Abdul Ghaffar, James C Lee, Christopher Bianco, Mikiko Shimizu, Tsuyoshi Shiga, Masayuki Hashiguchi
Publikováno v:
PLoS ONE, Vol 16, Iss 6, p e0252549 (2021)
Current American College of Cardiology/American Heart Association guidelines for stroke or ST-elevation myocardial infarction recommend the use of oral vitamin K antagonists (VKAs) as a first-line anticoagulant. Although several studies have compared
Externí odkaz:
https://doaj.org/article/21c1cfb0f1bc47e3968ebeed42b64ed6
Publikováno v:
Currents in Pharmacy Teaching and Learning. 14:1500-1505
The layered learning model (LLM) is a well-established teaching approach designed for attending preceptors to train post-graduate learners and to precept students. The adaptation of a LLM to a virtual exchange program has not been previously describe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f32e44167cf7b885de2819267fcbf07
https://doi.org/10.1016/j.cptl.2022.10.006
https://doi.org/10.1016/j.cptl.2022.10.006
Autor:
GEORGE Sokos, KAZUHIKO KIDO, GURUSHER PANJRATH, EMILY BENTON, ROBERT PAGE, JIGNESH PATEL, PATRICK J. SMITH, SHELLY KOROUS, Maya GUGLIN
Publikováno v:
Journal of Cardiac Failure.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a9201eeb9dc6a4450e5223013c049f0f
https://doi.org/10.1016/j.cardfail.2023.02.011
https://doi.org/10.1016/j.cardfail.2023.02.011
Autor:
Kazuhiko Kido, Bailey M. Colvin, Rachael Broscious, Sydney Bongiorni, George Sokos, Khalid M. Kamal
Publikováno v:
Annals of Pharmacotherapy. 56:1203-1209
Background: Clinical pharmacists play pivotal roles in multidisciplinary heart failure (HF) teams through the management of HF pharmacotherapy, but no study has examined the economic impact of HF ambulatory clinical pharmacists in an advanced HF clin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::939fbdc61a8af62f032249aa9aafb1bb
https://doi.org/10.1177/10600280221075755
https://doi.org/10.1177/10600280221075755
Autor:
Usha Sambamoorthi, Ranjita Misra, Traci LeMasters, Danielle E. Rose, Nilanjana Dwibedi, Kazuhiko Kido, Khalid Alhussain
Publikováno v:
Future Cardiol
Aim: To identify knowledge gaps in heart failure (HF) research among women, especially postmenopausal women. Materials & methods: We retrieved HF articles from PubMed. Natural language processing and text mining techniques were used to screen relevan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7f0de52eacf19a37faf88b89f43d0894
https://doi.org/10.2217/fca-2020-0083
https://doi.org/10.2217/fca-2020-0083
Autor:
Kazuhiko Kido, Christopher Bianco, Marco Caccamo, Masayuki Hashiguchi, Lyn Yuen Choo, George Sokos
Publikováno v:
Journal of Pharmacy Practice. :089719002311772
Background There is no standard approach for managing the use or dose of loop diuretics after initiating sacubitril/valsartan. Objective To investigate longitudinal trends in loop diuretic therapy use and doses during the initial 6 months following s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b175ed00e2c4f475e6b9ff80a30ceaf5
https://doi.org/10.1177/08971900231177202
https://doi.org/10.1177/08971900231177202
Publikováno v:
Ann Pharmacother
Background Limited evidence is available regarding low (24/26 mg) and middle (49/51 mg) doses of sacubitril/valsartan. Objectives The purpose of this study was to investigate the effect of sacubitril/valsartan dose on heart failure (HF) hospitalizati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::648cebee82c34a56a7af2404b27e0409
https://doi.org/10.1177/1060028020983522
https://doi.org/10.1177/1060028020983522
Publikováno v:
The American Journal of Cardiology. 126:23-28
The International Society of Thrombosis and Haemostasis recommends warfarin therapy over direct oral anticoagulants (DOACs) in patients with a body mass index >40 kg/m2 or weight > 120 kg due to limited clinical data in morbidly obese patients. The a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f5f4d2a602d77d0a68a03783de530c7
https://doi.org/10.1016/j.amjcard.2020.03.048
https://doi.org/10.1016/j.amjcard.2020.03.048
Publikováno v:
Journal of cardiac failure. 28(7)
Sacubitril/valsartan is an angiotensin receptor/neprilysin inhibitor that the Food and Drug Administration has indicated to reduce the risk of cardiovascular hospitalization and death in patients with left ventricular ejection fraction below normal a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bebad0faf1bc9e27612cab1ce9f54d66
https://pubmed.ncbi.nlm.nih.gov/35405341
https://pubmed.ncbi.nlm.nih.gov/35405341
Publikováno v:
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 40:72-83
In 2016, the International Society on Thrombosis and Haemostasis (ISTH) published guidelines advising caution when using direct oral anticoagulants (DOACs) in patients with morbid obesity due to limited clinical efficacy and safety data supporting th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7f69d1c13e5188991008487651a814cc
https://doi.org/10.1002/phar.2353
https://doi.org/10.1002/phar.2353